BMI1 and cancer: Importantly, BMI1 is frequently upregulated and its expression correlates with poor prognosis and therapy failure in several types of cancer including OvCa [15–18] Experimental reduction of BMI1 increases susceptibility to cytotoxic agents and radiation therapy [15, 19].